Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Short- and Long-Term Outcome of Systemic Lupus Erythematosus Peripheral Neuropathy: Bimodal Pattern of Onset and Treatment Response.

Fargetti S, Ugolini-Lopes MR, Pasoto SG, Seguro LPC, Shinjo SK, Bonfa E, Borba EF.

J Clin Rheumatol. 2019 Oct 22. doi: 10.1097/RHU.0000000000001201. [Epub ahead of print]

PMID:
31651643
2.

Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?

Ugolini-Lopes MR, Gavinier SS, Leon E, Viana VT, Borba EF, Bonfá E.

Clin Rheumatol. 2019 Oct;38(10):2777-2783. doi: 10.1007/s10067-019-04620-3. Epub 2019 Jun 2.

PMID:
31154554
3.

Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases.

Pileggi GS, Da Mota LMH, Kakehasi AM, De Souza AW, Rocha A, de Melo AKG, da Fonte CAM, Bortoletto C, Brenol CV, Marques CDL, Zaltman C, Borba EF, Reis ER, Freire EAM, Klumb EM, Christopoulos GB, Laurindo IMM, Ballalai I, Da Costa IP, Michelin L, de Azevêdo Valadares LD, Chebli LA, Lacerda M, Toscano MAF, Yazbek MA, De Abreu Vieira RMR, Magalhães R, Kfouri R, Richtmann R, Merenlender SDCS, Valim V, De Assis MR, Kowalski SC, Trevisani VFM.

Adv Rheumatol. 2019 Apr 29;59(1):17. doi: 10.1186/s42358-019-0056-x.

PMID:
31036077
4.

Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients.

Tiseo BC, Bonfá E, Borba EF, Munhoz GA, Wood G, Srougi M, Silva CA, Cocuzza M.

Lupus. 2019 Jan;28(1):59-65. doi: 10.1177/0961203318815764. Epub 2018 Dec 3.

PMID:
30509155
5.

Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression.

Castro M, Ugolini-Lopes M, Borba EF, Bonfá E, Seguro LPC.

Lupus. 2018 Dec;27(14):2215-2219. doi: 10.1177/0961203318809883. Epub 2018 Nov 4.

PMID:
30394834
6.

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.

Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez-Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Solomons N, Houssiau FA, Romero-Diaz J, Mejia-Vilet J, Rovin BH.

Arthritis Rheumatol. 2019 Mar;71(3):411-419. doi: 10.1002/art.40724. Epub 2019 Feb 1.

PMID:
30225865
7.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Reyes GL, Acosta Colman MI, Aquino AM, Mora-Trujillo CS, Muñoz-Louis R, García Valladares I, Orozco MC, Burgos PI, Betancur GV, Alarcón GS; Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR).

Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25.

8.

High prevalence of metabolic syndrome in antisynthetase syndrome.

Araujo PAO, Silva MG, Borba EF, Shinjo SK.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):241-247. Epub 2018 Apr 18.

PMID:
29716676
9.

Peliosis hepatis and systemic lupus erythematosus: A rare condition identified by magnetic resonance imaging.

Cordeiro RA, Hoff LS, Garcia MVF, Leão Filho HM, Borba EF.

Rev Assoc Med Bras (1992). 2018 Jan;64(1):19-21. doi: 10.1590/1806-9282.64.01.19.

10.

Serum uric acid levels are associated with lupus nephritis in patients with normal renal function.

Calich AL, Borba EF, Ugolini-Lopes MR, da Rocha LF, Bonfá E, Fuller R.

Clin Rheumatol. 2018 May;37(5):1223-1228. doi: 10.1007/s10067-018-3991-8. Epub 2018 Jan 20.

PMID:
29353328
11.

Early proteinuria response: a valid real-life situation predictor of long-term lupus renal outcome in an ethnically diverse group with severe biopsy-proven nephritis?

Ugolini-Lopes MR, Seguro LPC, Castro MXF, Daffre D, Lopes AC, Borba EF, Bonfá E.

Lupus Sci Med. 2017 Jun 12;4(1):e000213. doi: 10.1136/lupus-2017-000213. eCollection 2017.

12.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2017 Dec;76(12):2071-2074. doi: 10.1136/annrheumdis-2017-211814. Epub 2017 Sep 22.

PMID:
28939626
13.

Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients.

Silva MG, Borba EF, Mello SB, Shinjo SK.

Clinics (Sao Paulo). 2016 Dec 1;71(12):709-714. doi: 10.6061/clinics/2016(12)06.

14.

Ozone decreases sperm quality in systemic lupus erythematosus patients.

Farhat J, Farhat SC, Braga AL, Cocuzza M, Borba EF, Bonfá E, Silva CA.

Rev Bras Reumatol Engl Ed. 2016 May-Jun;56(3):212-9. doi: 10.1016/j.rbre.2015.08.005. Epub 2015 Nov 23. English, Portuguese.

15.

Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients.

Gormezano NW, Otsuzi CI, Barros DL, da Silva MA, Pereira RM, Campos LM, Borba EF, Bonfá E, Silva CA.

Semin Arthritis Rheum. 2016 Jun;45(6):706-10. doi: 10.1016/j.semarthrit.2015.10.015. Epub 2015 Nov 5.

PMID:
26833399
16.

Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease?

Pugliese C, van der Vinne RT, Campos LM, Guardieiro PR, Saviolli C, Bonfá E, Pereira RM, Viana VS, Borba EF, Silva CA.

Clin Rheumatol. 2016 Jan;35(1):81-91. doi: 10.1007/s10067-015-3125-5. Epub 2015 Dec 1.

PMID:
26626632
17.

Carpal tunnel syndrome and prediabetes: is there a true association?

Sousa Vasconcelos JT, Freitas Paiva ÂM, Cavalcanti MF, de Carvalho JF, Bonfá E, Borba EF.

Clin Neurol Neurosurg. 2015 Oct;137:57-61. doi: 10.1016/j.clineuro.2015.06.015. Epub 2015 Jun 23.

PMID:
26150169
18.

Impact of Therapy on Metabolic Syndrome in Young Adult Premenopausal Female Lupus Patients: Beneficial Effect of Antimalarials.

Muniz LF, Pereira RMR, Silva TF, Bonfá E, Borba EF.

Arthritis Care Res (Hoboken). 2015 Sep;67(9):1255-1262. doi: 10.1002/acr.22593.

19.

Lupus in Latin-American patients: lessons from the GLADEL cohort.

Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA; GLADEL.

Lupus. 2015 May;24(6):536-45. doi: 10.1177/0961203314567753. Epub 2015 Feb 18. Review.

PMID:
25697768
20.

Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.

Pozzi FS, Maranhão RC, Guedes LK, Borba EF, Laurindo IM, Bonfa E, Vinagre CG.

J Clin Lipidol. 2015 Jan-Feb;9(1):72-80. doi: 10.1016/j.jacl.2014.10.004. Epub 2014 Nov 4.

PMID:
25670363
21.

ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?

Nascimento NM, Bydlowski SP, Soares RP, de Andrade DC, Bonfá E, Seguro LP, Borba EF.

J Thromb Thrombolysis. 2015 Oct;40(3):374-8. doi: 10.1007/s11239-015-1176-8.

PMID:
25638331
22.

Increased corticotropin-releasing hormone (CRH) expression in cutaneous lupus lesions.

Schmitz MK, Botte DA, Sotto MN, Borba EF, Bonfa E, de Mello SB.

Lupus. 2015 Jul;24(8):854-61. doi: 10.1177/0961203315569335. Epub 2015 Jan 28.

PMID:
25634068
23.

[Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis].

Klumb EM, Silva CA, Lanna CC, Sato EI, Borba EF, Brenol JC, de Albuquerque EM, Monticielo OA, Costallat LT, Latorre LC, Sauma Mde F, Bonfá ES, Ribeiro FM.

Rev Bras Reumatol. 2015 Jan-Feb;55(1):1-21. doi: 10.1016/j.rbr.2014.09.008. Epub 2014 Nov 1. Portuguese.

24.

Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity.

Choi JY, Ho JH, Pasoto SG, Bunin V, Kim ST, Carrasco S, Borba EF, Gonçalves CR, Costa PR, Kallas EG, Bonfa E, Craft J.

Arthritis Rheumatol. 2015 Apr;67(4):988-99. doi: 10.1002/art.39020.

25.

Suppurative thyroiditis due to aspergillosis: a case report.

Marui S, de Lima Pereira AC, de Araújo Maia RM, Borba EF.

J Med Case Rep. 2014 Nov 21;8:379. doi: 10.1186/1752-1947-8-379.

26.

Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.

Aguila LA, Lopes MR, Pretti FZ, Sampaio-Barros PD, Carlos de Souza FH, Borba EF, Shinjo SK.

Clin Rheumatol. 2014 Aug;33(8):1093-8. doi: 10.1007/s10067-014-2730-z. Epub 2014 Jul 4.

PMID:
24989017
27.

Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?

de Araujo DB, Yamakami LY, Aikawa NE, Bonfá E, Viana VS, Pasoto SG, Pereira RM, Serafin PC, Borba EF, Silva CA.

Scand J Rheumatol. 2014;43(6):503-11. doi: 10.3109/03009742.2014.908237. Epub 2014 Jun 2.

PMID:
24881927
28.

Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.

Garcia CB, Seguro LP, Perandini LA, de Sá Pinto AL, Lima FR, Negrão CE, Bonfa E, Borba EF.

Rheumatol Int. 2014 Dec;34(12):1737-41. doi: 10.1007/s00296-014-3038-7. Epub 2014 May 14.

PMID:
24825252
29.

Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.

García MA, Alarcón GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, Gentiletti S, Caeiro F, Sato EI, Borba EF, Brenol JC, Massardo L, Molina-Restrepo JF, Vásquez G, Guibert-Toledano M, Barile-Fabris L, Amigo MC, Huerta-Yáñez GF, Cucho-Venegas JM, Chacón-Diaz R, Pons-Estel BA; Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL).

Rheumatology (Oxford). 2014 Aug;53(8):1431-8. doi: 10.1093/rheumatology/keu011. Epub 2014 Mar 14.

PMID:
24633413
30.

Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy.

Fabbri C, Fuller R, Bonfá E, Guedes LK, D'Alleva PS, Borba EF.

Clin Rheumatol. 2014 Apr;33(4):505-9. doi: 10.1007/s10067-013-2473-2. Epub 2014 Jan 11.

PMID:
24415114
31.

Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?

Rezende GM, Viana VS, Malheiros DM, Borba EF, Silva NA, Silva C, Leon EP, Noronha IL, Bonfa E.

Lupus. 2014 Mar;23(3):255-62. doi: 10.1177/0961203313517152. Epub 2013 Dec 19.

PMID:
24356611
32.

Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus.

Teixeira RA, Borba EF, Pedrosa A, Nishioka S, Viana VS, Ramires JA, Kalil-Filho R, Bonfá E, Martinelli Filho M.

Europace. 2014 Jun;16(6):887-92. doi: 10.1093/europace/eut290. Epub 2013 Sep 19.

PMID:
24050965
33.

Impaired aerobic exercise capacity and cardiac autonomic control in primary antiphospholipid syndrome.

Garcia CB, Perandini LA, Seguro LP, Gualano B, Roschel H, Bonfa E, Borba EF, Sá-Pinto AL.

Lupus. 2013 Aug;22(9):928-31. doi: 10.1177/0961203313497415.

PMID:
23894046
34.

Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.

Pons-Estel GJ, Alarcón GS, Burgos PI, Hachuel L, Boggio G, Wojdyla D, Nieto R, Alvarellos A, Catoggio LJ, Guibert-Toledano M, Sarano J, Massardo L, Vásquez GM, Iglesias-Gamarra A, Lavras Costallat LT, Da Silva NA, Alfaro JL, Abadi I, Segami MI, Huerta G, Cardiel MH, Pons-Estel BA; Grupo Latino Americano de Estudio de Lupus (GLADEL).

Lupus. 2013 Aug;22(9):899-907. doi: 10.1177/0961203313496339. Epub 2013 Jul 15.

35.

Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations.

Borba EF, Araujo DB, Bonfá E, Shinjo SK.

Lupus. 2013 Jun;22(7):744-9. doi: 10.1177/0961203313490432. Epub 2013 May 17.

PMID:
23687065
36.

Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis.

Calich AL, Viana VS, Cancado E, Tustumi F, Terrabuio DR, Leon EP, Silva CA, Borba EF, Bonfa E.

Liver Int. 2013 Jul;33(6):909-13. doi: 10.1111/liv.12155. Epub 2013 Mar 24.

PMID:
23522300
37.

Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.

Cairoli E, Rebella M, Danese N, Garra V, Borba EF.

Lupus. 2012 Oct;21(11):1178-82. doi: 10.1177/0961203312450084. Epub 2012 May 28.

PMID:
22641182
38.

Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial.

Miossi R, Benatti FB, Lúciade de Sá Pinto A, Lima FR, Borba EF, Prado DM, Perandini LA, Gualano B, Bonfá E, Roschel H.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1159-66. doi: 10.1002/acr.21678.

39.

Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus.

Araujo DB, Borba EF, Silva CA, Campos LM, Pereira RM, Bonfa E, Shinjo SK.

Lupus. 2012 Jul;21(8):872-7. doi: 10.1177/0961203312441047. Epub 2012 Mar 16.

PMID:
22427319
40.

Increased arterial stiffness assessed by pulse wave velocity in Behçet's disease and its association with the lipid profile.

Caldas CA, Borba EF, Bortolotto LA, Medeiros DM, Bonfa E, Gonçalves CR.

J Eur Acad Dermatol Venereol. 2013 Apr;27(4):454-9. doi: 10.1111/j.1468-3083.2012.04458.x. Epub 2012 Feb 13.

PMID:
22329367
41.

Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?

Borba EF, Saad CG, Pasoto SG, Calich AL, Aikawa NE, Ribeiro AC, Moraes JC, Leon EP, Costa LP, Guedes LK, Silva CA, Goncalves CR, Fuller R, Oliveira SA, Ishida MA, Precioso AR, Bonfa E.

Rheumatology (Oxford). 2012 Jun;51(6):1061-9. doi: 10.1093/rheumatology/ker427. Epub 2012 Jan 31.

PMID:
22298793
42.

Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis.

Marangoni RG, Hayata AL, Borba EF, Azevedo PM, Bonfá E, Schainberg CG.

Clinics (Sao Paulo). 2011;66(9):1549-52.

43.

Cholesterol and chloroquine.

Borba EF.

Rev Bras Reumatol. 2011 Dec;51(6):673. English, Portuguese. No abstract available.

PMID:
22124601
44.

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.

Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.

Ann Rheum Dis. 2011 Dec;70(12):2144-7. doi: 10.1136/ard.2011.152983. Epub 2011 Aug 22.

PMID:
21859696
45.

Cutting-edge issues in autoimmune orchitis.

Silva CA, Cocuzza M, Borba EF, Bonfá E.

Clin Rev Allergy Immunol. 2012 Apr;42(2):256-63. doi: 10.1007/s12016-011-8281-z. Review.

PMID:
21842235
46.

Abnormal chronotropic reserve and heart rate recovery in patients with SLE: a case-control study.

do Prado DL, Gualano B, Miossi R, Sá-Pinto A, Lima F, Roschel H, Borba E, Bonfá E.

Lupus. 2011 Jun;20(7):717-20. doi: 10.1177/0961203310397081.

PMID:
21596946
47.

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.

Saad CG, Borba EF, Aikawa NE, Silva CA, Pereira RM, Calich AL, Moraes JC, Ribeiro AC, Viana VS, Pasoto SG, Carvalho JF, França IL, Guedes LK, Shinjo SK, Sampaio-Barros PD, Caleiro MT, Goncalves CR, Fuller R, Levy-Neto M, Timenetsky Mdo C, Precioso AR, Bonfa E.

Ann Rheum Dis. 2011 Jun;70(6):1068-73. doi: 10.1136/ard.2011.150250.

PMID:
21540203
48.

Penile anthropometry in systemic lupus erythematosus patients.

Vecchi AP, Borba EF, Bonfá E, Cocuzza M, Pieri P, Kim CA, Silva CA.

Lupus. 2011 Apr;20(5):512-8. doi: 10.1177/0961203310384121. Epub 2011 Jan 31.

PMID:
21282296
49.

Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.

Paraiba DB, Soares CR, Bartolini P, Arthuso FS, Borba EF, Bonfa E, Bronstein MD.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):866-72. Epub 2011 Jan 3.

PMID:
21205462
50.

Arrhythmias in systemic lupus erythematosus.

Teixeira RA, Borba EF, Bonfá E, Martinelli Filho M.

Rev Bras Reumatol. 2010 Jan-Feb;50(1):81-9. Review. English, Portuguese.

PMID:
21125143

Supplemental Content

Loading ...
Support Center